Breast Cancer Research : Bcr
-
Publication Venue For
- Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers.. 20:90. 2018
- Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.. 20:22. 2018
- Frequency of breast cancer subtypes among African American women in the AMBER consortium.. 20:12. 2018
- Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.. 19:131. 2017
- Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.. 19:18. 2017
- Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.. 18:68. 2016
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.. 18:64. 2016
- Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth.. 17:528. 2015
- Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.. 17:128. 2015
- Micro-anatomical quantitative optical imaging: toward automated assessment of breast tissues.. 17:105. 2015
- Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.. 17:91. 2015
- Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth.. 17:20. 2015
- Lobular breast cancer series: Imaging. 17. 2015
- Lobular breast cancer series: imaging.. 17:94. 2015
- Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance 2015
- An unexpected alliance between stress responses to drive oncogenesis.. 16:471. 2014
- DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.. 16:450. 2014
- A joint analysis of metabolomics and genetics of breast cancer.. 16:415. 2014
- A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.. 16:407. 2014
- Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.. 15:R74. 2013
- Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.. 15:R101. 2013
- Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women.. 14:R141. 2012
- Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.. 14:R129. 2012
- Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.. 14:R42. 2012
- Cell-extrinsic consequences of epithelial stress: Activation of protumorigenic tissue phenotypes. 14. 2012
- Correction: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer. 13. 2011
- Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.. 13:R62. 2011
- Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.. 13:205. 2011
- Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.. 13:R110. 2011
- Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.. 13:R125. 2011
- Akt is required for Stat5 activation and mammary differentiation.. 12:R72. 2010
- An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.. 11:R55. 2009
- Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study.. 11:R49. 2009
- Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. 10. 2008
- HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors. 9. 2007
- Predicting a local recurrence after breast-conserving therapy by gene expression profiling. 8. 2006
- Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites.. 6:R264-R274. 2004